Characterizing a Novel RasGRP1-mTOR Pathway in Immune and Cancer Cells


Momentum Fellow (2020-2022)

Kriti Bahl, PhD, University of California, San Francisco

Kriti Bahl, PhD

Dr. Bahl is investigating how the RasGRP1-mTORC1 pathway leads to an altered metabolic state in naïve T cells and how it functions in leukemia and other cancer types.

published research

Hysenaj L, Little S, Kulhanek K, Magnen M, Bahl K, Gbenedio OM, Prinz M, Rodriguez L, Andersen C, Rao AA, Shen A, Lone JC, Lupin-Jimenez LC, Bonser LR, Serwas NK, Mick E, Khalid MM, Taha TY, Kumar R, Li JZ, Ding VW, Matsumoto S, Maishan M, Sreekumar B, Simoneau C, Nazarenko I, Tomlinson MG, Khan K, von Gottberg A, Sigal A, Looney MR, Fragiadakis GK, Jablons DM, Langelier CR, Matthay M, Krummel M, Erle DJ, Combes AJ, Sil A, Ott M, Kratz JR, Roose JP. SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants. Stem Cell Reports. 2023.

BACK TO OUR PORTFOLIO